Analysts Offer Insights on Healthcare Companies: Fresenius Medical Care (FMS), Merck & Company (MRK) and Insmed (INSM)
Bernstein Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Erste Group Initiates Fresenius Medical Care(FMS.US) With Buy Rating
Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
BofA Securities Maintains Fresenius Medical Care(FMS.US) With Hold Rating
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating
Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
UBS Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Maintains Target Price $26
Cautious Optimism: Hold Rating for Fresenius Medical Care Amid Positive Q3 Performance and 2025 Growth Projections
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell From J.P. Morgan
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell From J.P. Morgan
Fresenius Medical Care Raised to Hold From Sell by Warburg
Fresenius Medical Care Target Raised to EUR43 From EUR36 by Warburg
UBS Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Raises Target Price to $26
Berenberg Bank Maintains Fresenius Medical Care(FMS.US) With Buy Rating, Raises Target Price to $28.9
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy From Berenberg Bank
Berenberg Bank Reaffirms Their Buy Rating on Fresenius Medical Care (FMS)